Education
About Us
Working with TipRanks
Follow Us
Ribomic, Inc. (JP:4591)
:4591
4591 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥60.00 - ¥141.00
Previous CloseN/A
Volume38.87M
Average Volume (3M)2.80M
Market Cap
¥4.91B
Enterprise Value¥3.07B
Total Cash (Recent Filing)¥3.10B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.33
Shares Outstanding44,613,940
10 Day Avg. Volume1,237,200
30 Day Avg. Volume2,798,536
Financial Highlights & Ratios
PEG Ratio9.20
Price to Book (P/B)1.59
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ribomic, Inc. News
PremiumCompany Announcements
Ribomic Inc. Reports Continued Net Loss for Fiscal Year 2025
PremiumCompany Announcements
Ribomic Sees Reduced Losses in Latest Financial Report
PremiumCompany Announcements
Ribomic Inc. Reports Quarterly Loss, Stable Assets4591 FAQ
What was Ribomic, Inc.’s price range in the past 12 months?
Ribomic, Inc. lowest stock price was ¥60.00 and its highest was ¥141.00 in the past 12 months.
What is Ribomic, Inc.’s market cap?
Ribomic, Inc.’s market cap is ¥4.91B.
When is Ribomic, Inc.’s upcoming earnings report date?
Ribomic, Inc.’s upcoming earnings report date is Aug 12, 2025 which is in 25 days.
How were Ribomic, Inc.’s earnings last quarter?
Currently, no data Available
Is Ribomic, Inc. overvalued?
According to Wall Street analysts Ribomic, Inc.’s price is currently Overvalued.
Does Ribomic, Inc. pay dividends?
Ribomic, Inc. does not currently pay dividends.
What is Ribomic, Inc.’s EPS estimate?
Ribomic, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ribomic, Inc. have?
Ribomic, Inc. has 44,613,940 shares outstanding.
What happened to Ribomic, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ribomic, Inc.?
Currently, no hedge funds are holding shares in JP:4591
Company Description
Ribomic, Inc.
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Technical Analysis
Immuno-Biological Laboratories Co., Ltd.
―
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
BrightPath Biotherapeutics Co.Ltd.
―
FunPep Company Limited
―